Gero Hütter

4.4k total citations · 2 hit papers
48 papers, 2.8k citations indexed

About

Gero Hütter is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, Gero Hütter has authored 48 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Virology and 15 papers in Immunology. Recurrent topics in Gero Hütter's work include HIV Research and Treatment (18 papers), Immune Cell Function and Interaction (10 papers) and HIV/AIDS drug development and treatment (6 papers). Gero Hütter is often cited by papers focused on HIV Research and Treatment (18 papers), Immune Cell Function and Interaction (10 papers) and HIV/AIDS drug development and treatment (6 papers). Gero Hütter collaborates with scholars based in Germany, United States and Netherlands. Gero Hütter's co-authors include Eckhard Thiel, Thomas Schneider, Kristina Allers, Jörg Hofmann, Susanne Ganepola, Daniel Nowak, Maximilian Mossner, Igor Wolfgang Blau, Wolf K. Hofmann and Olga Blau and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Gero Hütter

45 papers receiving 2.7k citations

Hit Papers

Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cel... 2009 2026 2014 2020 2009 2010 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gero Hütter Germany 20 1.5k 1.2k 810 631 421 48 2.8k
Jinghe Huang China 22 1.2k 0.8× 646 0.6× 854 1.1× 989 1.6× 130 0.3× 52 2.5k
Andrew J. Henderson United States 29 1.1k 0.8× 855 0.7× 592 0.7× 1.1k 1.7× 193 0.5× 73 2.4k
Julie Strizki United States 26 1.5k 1.0× 466 0.4× 1.2k 1.5× 828 1.3× 333 0.8× 65 2.6k
Ramin B. Arani United States 16 1.2k 0.8× 584 0.5× 772 1.0× 572 0.9× 247 0.6× 27 2.3k
Nesrina Imami United Kingdom 30 950 0.7× 322 0.3× 565 0.7× 1.5k 2.3× 389 0.9× 104 2.6k
Scott G. Kitchen United States 31 1.4k 1.0× 650 0.6× 651 0.8× 1.5k 2.4× 672 1.6× 72 2.9k
Vincent Vieillard France 34 581 0.4× 458 0.4× 574 0.7× 3.1k 4.9× 872 2.1× 99 4.1k
A. Benedetto Italy 27 524 0.4× 630 0.5× 509 0.6× 381 0.6× 303 0.7× 94 2.1k
Н. П. Шарова Russia 19 1.4k 1.0× 1.3k 1.1× 871 1.1× 517 0.8× 185 0.4× 66 2.7k
Hongmin Chen United States 19 342 0.2× 786 0.7× 305 0.4× 398 0.6× 282 0.7× 33 1.6k

Countries citing papers authored by Gero Hütter

Since Specialization
Citations

This map shows the geographic impact of Gero Hütter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gero Hütter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gero Hütter more than expected).

Fields of papers citing papers by Gero Hütter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gero Hütter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gero Hütter. The network helps show where Gero Hütter may publish in the future.

Co-authorship network of co-authors of Gero Hütter

This figure shows the co-authorship network connecting the top 25 collaborators of Gero Hütter. A scholar is included among the top collaborators of Gero Hütter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gero Hütter. Gero Hütter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hölig, Kristina, Helmuth Schmidt, Gero Hütter, et al.. (2020). Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial. Bone Marrow Transplantation. 56(3). 635–645. 11 indexed citations
2.
Teipel, Raphael, Uta Oelschlägel, Michael Krämer, et al.. (2018). Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor. Biology of Blood and Marrow Transplantation. 24(11). 2171–2177. 24 indexed citations
3.
Hütter, Gero. (2018). Die Heilung des Timothy Brown. MMW - Fortschritte der Medizin. 160(S2). 27–30. 1 indexed citations
4.
Hütter, Gero. (2016). Stem cell transplantation in strategies for curing HIV/AIDS. AIDS Research and Therapy. 13(1). 31–31. 27 indexed citations
5.
Burbelo, Peter D., Ardeshir Bayat, Craig Rhodes, et al.. (2013). HIV Antibody Characterization as a Method to Quantify Reservoir Size During Curative Interventions. The Journal of Infectious Diseases. 209(10). 1613–1617. 38 indexed citations
6.
Symons, Jori, Steven G. Deeks, Gero Hütter, et al.. (2012). The cure of the 'Berlin patient': why did pre-existing X4-variants not emergence after allogeneic CCR5-Delta 32 SCT?. Journal of the International AIDS Society. 15. 17–18. 3 indexed citations
7.
Allers, Kristina, Gero Hütter, Jörg Hofmann, et al.. (2010). Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. Blood. 117(10). 2791–2799. 500 indexed citations breakdown →
8.
Hütter, Gero, Martin Kaiser, Martín Neumann, et al.. (2010). Epigenetic regulation of PAX5 expression in acute T-cell lymphoblastic leukemia. Leukemia Research. 35(5). 614–619. 14 indexed citations
9.
Hütter, Gero, Daniel Nowak, Maximilian Mossner, et al.. (2009). Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation. New England Journal of Medicine. 360(7). 692–698. 1250 indexed citations breakdown →
10.
Hütter, Gero, Susanne Ganepola, & Wolf‐K. Hofmann. (2008). The hematology of anorexia nervosa. International Journal of Eating Disorders. 42(4). 293–300. 91 indexed citations
12.
Busse, Antonia, Gero Hütter, Jan Siehl, et al.. (2007). A phase I/IIa clinical trial of CLAOP21 and CLAOP14 in patients with high grade non-Hodgkins lymphoma. Leukemia & lymphoma. 48(9). 1755–1763.
13.
Siehl, Jan, Eckhard Thiel, Alexander Schmittel, et al.. (2005). Ifosfamide/liposomal daunorubicin is a well tolerated and active first‐line chemotherapy regimen in advanced soft tissue sarcoma. Cancer. 104(3). 611–617. 21 indexed citations
14.
Schmittel, Alexander, et al.. (2004). Phase I Dose Escalation Study of Carboplatin to a Fixed Dose of Irinotecan as First-Line Treatment of Small Cell Lung Cancer. Oncology Research and Treatment. 27(3). 280–284. 8 indexed citations
15.
Sinha, Pranav, Julia Poland, Sandro Kohl, et al.. (2003). Study of the development of chemoresistance in melanoma cell lines using proteome analysis. Electrophoresis. 24(14). 2386–2404. 48 indexed citations
16.
Hütter, Gero & Pranav Sinha. (2001). Proteomics for studying cancer cells and the development of chemoresistance. PROTEOMICS. 1(10). 1233–1248. 40 indexed citations
17.
Sinha, Pranav, Jochen Fischer, Gero Hütter, et al.. (2000). Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis. Electrophoresis. 21(14). 3048–3057. 96 indexed citations
20.
Sinha, Pranav, Gero Hütter, Eckart Köttgen, et al.. (1998). Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug resistant human stomach cancer cells. Journal of Biochemical and Biophysical Methods. 37(3). 105–116. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026